In 2022, the Fonds de recherche du Québec – Santé (FRQS) is proud to announce the resumption of its activities in the calls of proposals (JTC2022) as a financial partner under the European research networks such as ERA-NETs and EJPs. Multilateral joint transnational calls for proposals to support international collaborative research have been recently launched in the areas of Personalised medicine and Rare diseases:

  • Rare diseases (EJP RD Network), research projects focus on Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases

Announcement
Date for the Call launch was December 14, 2021
Deadline to submit a letter of intent is February 16, 2022

This opportunity is be offered in co-funding with the CIHR Institute of Genetics (CIHR-IG) who will maximize their funding efforts.
More information on FRQS’ web page

  • Personalised medicine (ERA PerMed Network), call for interdisciplinary proposals and transnational collaboration on PREVENTION IN PERSONALISED MEDICINE. Three (3) main Research Areas, each with Two (2) Modules, for Eight (8) modules in total can be addressed.

Announcement
Date for the Call launch was December 1st, 2021
Deadline to submit a letter of intent is February 17, 2022 
More information on FRQS’ Web page

In addition, the FRQS announces the resumption of its activities under the ERA-NET NEURON call (JTC2022) for collaborative projects to support international research currently in preliminary announcement in the field of Neurosciences.

  • Neuroscience (ERA-NET NEURON Network), call for interdisciplinary proposals and transnational collaboration on CEREBROVASCULAR DISEASES INCLUDING SMALL VESSEL AND BRAIN BARRIERS DYSFUNCTION.
Preliminary announcement
Expected date for the Call launch is January 7, 2022.
Expected deadline to submit a letter of intent is March 2022.
More information on FRQS’ web page

Information
Maxime Beaudoin
Programs Manager – International team Grants
Fonds de recherche du Québec – Santé
514 873-2114, ext. 4369